Icu Medical [ICUI] vs Baxter International [BAX] Detailed Stock Comparison

Icu Medical Inc.

NASDAQ
Loading...

Baxter International Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Icu Medical Inc. wins in 9 metrics, Baxter International Inc. wins in 11 metrics, with 0 ties. Baxter International Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Icu Medical Inc. Baxter International Inc. Better
P/E Ratio (TTM) 4,245.33 86.31 Baxter International Inc.
Price-to-Book Ratio 1.48 1.54 Icu Medical Inc.
Debt-to-Equity Ratio 63.48 160.28 Icu Medical Inc.
PEG Ratio -124.79 0.73 Baxter International Inc.
EV/EBITDA 13.48 8.55 Baxter International Inc.
Profit Margin (TTM) 0.03% -8.51% Icu Medical Inc.
Operating Margin (TTM) 4.82% 7.36% Baxter International Inc.
EBITDA Margin (TTM) 4.82% 7.36% Baxter International Inc.
Return on Equity 0.04% -13.71% Icu Medical Inc.
Return on Assets (TTM) 1.66% 2.83% Baxter International Inc.
Free Cash Flow (TTM) $82.83M $323.00M Baxter International Inc.
Dividend Yield N/A 1.77% N/A
1-Year Return 0.39% -38.43% Icu Medical Inc.
Price-to-Sales Ratio (TTM) 1.43 0.85 Baxter International Inc.
Enterprise Value $4.18B $17.26B Baxter International Inc.
EV/Revenue Ratio 1.87 1.54 Baxter International Inc.
Gross Profit Margin (TTM) 37.54% 19.40% Icu Medical Inc.
Revenue per Share (TTM) $91 $22 Icu Medical Inc.
Earnings per Share (Diluted) $0.03 $-1.75 Icu Medical Inc.
Beta (Stock Volatility) 0.85 0.62 Baxter International Inc.
Short % of Float 6.25% 12.33% Icu Medical Inc.

Icu Medical Inc. vs Baxter International Inc. Stock Performance Analysis

Loading Price Chart...

ICUI
BAX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Icu Medical Inc.0.03%-3.33%9.95%-11.23%-11.03%-5.81%
Baxter International Inc.-0.75%-3.61%12.39%-5.13%-0.85%-4.21%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Icu Medical Inc.0.39%-26.60%-34.21%29.31%223.74%231.11%
Baxter International Inc.-38.43%-54.56%-77.17%-56.81%-40.32%-9.28%

Performance & Financial Health Analysis: Icu Medical Inc. vs Baxter International Inc.

MetricICUIBAX
Market Information
Market Cap i$3.11B$9.38B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i266,5756,387,585
90 Day Avg. Volume i286,5127,931,785
Last Close$130.52$18.54
52 Week Range$107.00 - $160.29$15.73 - $32.04
% from 52W High-18.57%-42.13%
All-Time High$321.70 (Aug 06, 2018)$95.19 (Apr 20, 2020)
% from All-Time High-59.43%-80.52%
Growth Metrics
Quarterly Revenue Growth-0.14%0.08%
Quarterly Earnings Growth-0.14%0.08%
Financial Health
Profit Margin (TTM) i0.00%-0.09%
Operating Margin (TTM) i0.05%0.07%
Return on Equity (TTM) i0.00%-0.14%
Debt to Equity (MRQ) i63.48160.28
Cash & Liquidity
Book Value per Share (MRQ)$86.03$11.92
Cash per Share (MRQ)$12.63$3.82
Operating Cash Flow (TTM) i$179.85M$845.00M
Levered Free Cash Flow (TTM) i$394.96M$2.43B
Dividends
Last 12-Month Dividend Yield iN/A1.77%
Last 12-Month Dividend iN/A$0.36

Valuation & Enterprise Metrics Analysis: Icu Medical Inc. vs Baxter International Inc.

MetricICUI (Apr 24, 2026)BAX (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i4,245.3386.31
Forward P/E i13.869.09
PEG Ratio i-124.790.73
Price to Sales (TTM) i1.430.85
Price to Book (MRQ) i1.481.54
Market Capitalization
Market Capitalization i$3.11B$9.38B
Enterprise Value i$4.18B$17.26B
Enterprise Value Metrics
Enterprise to Revenue i1.871.54
Enterprise to EBITDA i13.488.55
Risk & Other Metrics
Beta i0.850.62
Book Value per Share (MRQ) i$86.03$11.92

Financial Statements Comparison: Icu Medical Inc. vs Baxter International Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricICUI (2025)BAX (2025)
Revenue/Sales i2.23B11.24B
Cost of Goods Sold i1.41B7.87B
COGS % of Revenue i63.2%69.9%
Gross Profit i822.04M3.38B
Gross Margin i36.8%30.1%
Research & Development i87.50M518.00M
Operating Income (EBIT) i109.33M177.00M
Operating Margin i4.9%1.6%
EBITDA i320.73M1.26B
EBITDA Margin i14.4%11.2%
Pre-Tax Income i4.36M-505.00M
Pre-Tax Income % of Revenue i0.2%-4.5%
Income Tax i2.44M395.00M
Income Tax % of Revenue i0.1%3.5%
Net Income (Profit) i732,000-957.00M
Profit Margin i0.0%-8.5%

Balance Sheet & Liquidity Metrics

MetricICUI (2025)BAX (2025)
Cash & Equivalents i307.96M1.97B
Total Current Assets i1.19B6.87B
Total Current Assets % of Revenue i53.4%61.1%
Total Current Liabilities i498.86M2.97B
Total Current Liabilities % of Revenue i22.4%26.4%
Long-Term Debt i1.31B9.70B
Long-Term Debt % of Revenue i58.9%86.2%
Total Shareholders Equity i2.12B6.10B
Retained Earnings i690.89M13.71B
Retained Earnings % of Revenue i31.0%121.9%
Property, Plant & Equipment i492.78M651.00M

Cash Flow Statement Comparison

MetricICUI (2025)BAX (2025)
Operating Cash Flow i263.01M-24.00M
Operating Cash Flow % of Revenue i11.8%-0.2%
Capital Expenditures i-88.04MN/A
Free Cash Flow i82.83M323.00M
FCF Margin i3.7%2.9%
Debt Repayment i-304.80M-5.79B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricICUIBAX
Shares Short i1.30M40.31M
Short Ratio i4.684.11
Short % of Float i6.25%12.33%
Shares Outstanding i24.69M514.28M
Float Shares i24.21M512.05M
% Held by Insiders i3.79%0.32%
% Held by Institutions i114.71%109.89%
% Held by Public i-18.50%-10.21%

Dividend Analysis & Yield Comparison: Icu Medical Inc. vs Baxter International Inc.

MetricICUIBAX
Last 12-Month Dividend iN/A$0.36
Last 12-Month Dividend Yield iN/A1.77%
3-Year Avg Annual Dividend iN/A$0.81
3-Year Avg Dividend Yield iN/A0.57%
3-Year Total Dividends iN/A$2.44
Ex-Dividend DateN/AFeb 27, 2026